Merck: Investing in Science-Based Business (Abridged)
通常価格
¥1,078 JPY
通常価格
セール価格
¥1,078 JPY
単価
あたり
Ray Gilmartin faces a dilemma. His company's credibility has been damaged by the recent withdrawal of Vioxx, a multi-billion dollar drug. Moreover, the withdrawal of Vioxx would imply that Merck would fail to meet analysts' earnings expectations for 2005 unless Gilmartin cuts the R&D budget. Cutting the budget might hurt morale and productivity in Merck labs.
【書誌情報】
ページ数:5ページ
サイズ:A4
商品番号:HBSP-611027
発行日:2010/9/24
登録日:2012/7/17